Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Restaurant Industry News Kazia Therapeutics gets fast track status for paxalisib in glioblastoma Kazia Therapeutics, an Australian oncology company, has secured fast track designation (FTD) from the US Food and Drug… bypharmanewsdailyAugust 21, 2020